Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
clinicaladvisor.com
7h
Clesrovimab Looks Promising for RSV Prevention in Infants
Clesrovimab, formerly known as MK-1654, is an extended half-life RSV fusion glycoprotein neutralizing monoclonal antibody.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Linked to E. coli outbreak
To appear on Rogan podcast
Arrested in trafficking case
Veteran film producer dies
Splits with NY magazine
Target to cut prices
Trespassing charge upheld
To headline 2 Harris rallies
Hospitals' IV fluid shortage
Probing leak of US intel
Six indicted for fraud in Ohio
Ordered to hand over assets
SK mulls arms for Ukraine
Reveals 2025 tax brackets
Brain stimulation study
Giant ‘ghost’ fish spotted
Tests facial recognition tech
China holds live-fire drills
Same-day pharmacy delivery
2025 Medicare changes
Fuel pump concern recall
US semiconductor tax credit
FAA finalizes safety rules
Blinken arrives in Israel
GA election rules appeal
Raises US growth forecast
PA political threat case
FTC bans fake reviews
2 US troops injured in raid
Infant mortality increased
Right whale population rises
Related topics
RSV
Merck & Co.
Monoclonal antibody
Feedback